Clinical Trials in Arizona

Showing 4421-4440 of 16,770 trials

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

NCT05580588

Study SPH4336-US-01 is an open-label (no placebo), multicenter clinical trial to evaluate the safety, blood levels (pharmacokinetics) and preliminary anti-tumor effects of SPH4336, a selective enzyme blocker, in patients with specific types of liposarcomas (tumors expressing the target of the study drug).

Liposarcoma, Dedifferentiated

Shanghai Pharma Biotherapeutics USA Inc.14 participantsStarted Aug 2023

Phoenix, Arizona, United States • Duarte, California, United States • Jacksonville, Florida, United States +6 more locations

COMPLETEDPhase 342 miles

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

NCT03956355

This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.

Plaque Psoriasis

Organon and Co510 participantsStarted May 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Hot Springs, Arkansas, United States +50 more locations

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Find Trials by Condition in Arizona

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Reproductive Health Program in Patients With Cancer

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Pioglitazone for the Treatment of Alcohol Use Disorder

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Multi-Center Study of ManNAc for GNE Myopathy

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose